Ledger.Open graph →
SEC Form D · filed December 12, 2018

Checkmate Pharmaceuticals, Inc

Offering
$22.0M
Sold
$11.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Art Krieg · Cambridge, MAExec · DirectorCorey M. Goodman · Cambridge, MADirectorDavid M. Mauro · Cambridge, MAExecChuck Abdalian · Cambridge, MAExecMichael J. Powell · Billerica, MADirectorCharles M. Yon · Cambridge, MAExecKaren Brennan · Cambridge, MAExecMichele White · Windsor, CTExec · DirectorTimothy Murphy · Des Moines, IAExecC. R. Mullet · Reston, VADirectorClifford K. Holekamp · St. Louis, MODirectorJames Sinclair · Ithaca, X1ExecDonald P. Martin · Reston, VAExecRick L. Ryan · St. Louis, MOExecBen Auspitz · Bozeman, MTDirectorArthur Reidel · San Martin, CADirectorGerald Fitch · Newport Coast, CAExecAndrew Medvedev · New York, NYDirectorJames Wilmott · New York, NYExecThomas B. Doran · Minneapolis, MNExecStella Z. Xu, Ph.D · Solana Beach, CAExec · DirectorSimeon Z. George, M.D · Solana Beach, CAExecBen Auspitz · DURHAM, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗